Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
about
Can animal models of disease reliably inform human studies?Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical proceduresRemote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical proceduresTargeting of adenosine receptors in ischemia-reperfusion injury.Mechanical tissue resuscitation protects against myocardial ischemia-reperfusion injury.Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury.N-n-butyl haloperidol iodide inhibits H2O2-induced Na+/Ca2+-exchanger activation via the Na+/H+ exchanger in rat ventricular myocytesGlutathionylation of the L-type Ca2+ channel in oxidative stress-induced pathology of the heart.The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imagingNeuronal calcium homeostasis and dysregulation.Non-invasive evaluation of myocardial reperfusion by transthoracic Doppler echocardiography and single-photon emission computed tomography in patients with anterior acute myocardial infarction.Role of high-mobility group box-1 in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate.5'- Adenosine monophosphate induced hypothermia reduces early stage myocardial ischemia/reperfusion injury in a mouse model.Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagyThrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodelingcJun N-terminal kinase (JNK) phosphorylation of serine 36 is critical for p66Shc activationVagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflowRemote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI): study protocol for a randomized controlled trialMitochondria as a drug target in ischemic heart disease and cardiomyopathyExperimental and therapeutic opportunities for stem cells in multiple sclerosisComputational approaches to understand cardiac electrophysiology and arrhythmias.Superoxide flashes: illuminating new insights into cardiac ischemia/reperfusion injury.Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms.Targeting calcium transport in ischaemic heart disease.Orphan targets for reperfusion injury.Alternative Interventions to Prevent Oxidative Damage following Ischemia/ReperfusionSearching for NF-kappaB-based treatments of ischemia reperfusion injury.Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists.Novel effects of macrolide antibiotics on cardiovascular diseases.Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing.Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives.Ischemia-reperfusion injury and volatile anesthetics.NHE inhibition does not improve Na(+) or Ca(2+) overload during reperfusion: using modeling to illuminate the mechanisms underlying a therapeutic failure.Distribution of Systemically Administered Nanoparticles Reveals a Size-Dependent Effect Immediately following Cardiac Ischaemia-Reperfusion InjuryIntermittent pacing therapy favorably modulates infarct remodeling.Postconditioning against ischaemia-reperfusion injury: ready for wide application in patients?Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway.Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress.Clarithromycin attenuates myocardial ischemia-reperfusion injury.
P2860
Q21563449-69FB10E9-E231-4238-86E7-98F66EB99B8BQ24234559-B76079AE-AD9F-4EC6-9C5A-C18EEC2E4879Q24236243-E81B26D1-9464-4334-9D6E-232F4CCF04EAQ30429069-58E75672-2C96-406D-8CCA-89125B10DEAFQ33460111-06ECEBE0-D868-4483-A194-95140CADC46AQ34150566-7DE11221-FC76-440C-A40C-A5506722C6FFQ34201771-30721EB3-C5AE-4D13-B984-ED2BF28A0E70Q34487060-1AA7965A-F6B5-43B4-91DD-F018D8838A74Q34507513-32B19630-881E-4C44-8000-B270CD9AAAAAQ34624910-34605D35-EFF1-42C1-9E5D-30E376EAA92DQ35068344-1FE841B5-F96B-4E7A-9000-4FB620262B29Q35159715-CB13B73E-64B0-47F5-AE4C-6B5CE4AAB055Q35172554-A19C7291-F7B6-42CD-887E-2759A3CF67B8Q35753293-D85BD0A4-3A6A-404E-BB46-82FA8F24CFADQ35887746-300B4C21-790D-4F18-8915-01CE34E0AA7EQ35921419-4B03FD45-BB5A-4E8D-91F1-9807B4AED554Q35995878-E0F07AE6-032D-494D-831D-680226D0EC64Q36040821-B31C3EF4-17D3-489B-BC40-96771E0594ADQ36426316-29DF645A-AAEE-49EA-B19F-A9D9ABC0F6BAQ36432487-CCF10B7E-0167-49EC-B3B3-3101CB2E8A0EQ37174582-DD9F9378-866F-472E-9E4F-73AFF2DE4142Q37283753-ADB5AD28-EF62-4805-8098-51A94332E25CQ37375152-10E74C4F-93E7-4382-BB0D-BBFE49A82D03Q37422613-898CFB36-8751-42C1-ABFD-C4A2951ED20DQ37436743-0309F89B-918B-4F8A-B89F-C1E1BE604676Q37578724-209B93E8-9497-4997-B122-F82EF631D4DFQ37618218-63C8E591-9417-49BB-A462-1BBB3F76C5E1Q37668843-05087A3C-3151-44FB-8F7B-93F49380D241Q37964006-4A9ABFE9-6890-4096-A0DA-A81FF2A26177Q37974118-784DEEF2-ED5B-4561-A538-392EF4E5508CQ38087991-5205B53B-5DDF-438B-AA37-20493D6663CAQ38124357-547DFC87-4B18-42CA-AE66-FDD645EC6DE3Q38187663-B1A8B04A-2908-4B0F-A777-2FD6B20291A0Q38767537-08B15D74-52A7-48C6-9635-F941EE12047AQ41248810-0A42E109-0A7A-4407-81B6-0E3DFF721C75Q41838401-A3B69158-A1E2-4F77-AEF5-8181687E6BFDQ41848263-B334AE07-3047-489B-A225-8FCD81C510E1Q42126362-47729955-8B9A-409C-95F5-01524577785DQ42183251-50B609DE-E1BE-40FF-AA4C-F8EADCFC375DQ42956440-965C1663-D484-446B-9CC5-1039D086C203
P2860
Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reperfusion injury in humans: ...... injury inhibitory strategies.
@ast
Reperfusion injury in humans: ...... injury inhibitory strategies.
@en
type
label
Reperfusion injury in humans: ...... injury inhibitory strategies.
@ast
Reperfusion injury in humans: ...... injury inhibitory strategies.
@en
prefLabel
Reperfusion injury in humans: ...... injury inhibitory strategies.
@ast
Reperfusion injury in humans: ...... injury inhibitory strategies.
@en
P2093
P1476
Reperfusion injury in humans: ...... injury inhibitory strategies.
@en
P2093
Dirk J G M Duncker
Gerrit J Laarman
Maurits T Dirksen
P304
P356
10.1016/J.CARDIORES.2007.01.014
P577
2007-01-23T00:00:00Z